Last synced on 20 June 2025 at 11:06 pm

Software, Similarity Score Algorithm, Tissue Of Origin For Malignant Tumor Types

Page Type
Product Code
Definition
This test is intended to measure the degree of similarity between the RNA expression pattern in a patient?s fresh-frozen tumor and the RNA expression patterns in a database of tumor samples for some common malignant tumor types that were diagnosed according to then current clinical and pathological practice. The test result is intended for use in the context of the patient?s clinical history and other diagnostic tests evaluated by a qualified clinician. The test is not intended to establish the origin of tumors (e.g. carcinoma of unknown primary) that cannot be diagnosed according to current clinical and pathological practice.
Physical State
Gene expression systems, which include either microarray systems or reverse-transcriptase polymerase chain reaction (RT-PCR) systems. Steps for microarray systems include RNA isolation kits, cDNA synthesis kits, in vitro transcription kits, hybridization, washing and staining systems, scanner, and computer
Technical Method
Uses Gene expression and computer algorithm that estimate degree of similarity between analyzed specimen and examples of various tumor types comprising a database. Gene expression involves isolation of RNA from frozen tumor tissue sections, amplification of RNA and hybridization, and comparison of hybridization patterns.
Target Area
Fresh frozen tumor tissue sections
Regulation Medical Specialty
Toxicology
Review Panel
Toxicology
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
862.3100
GMP Exempt?
No
Summary Malfunction Reporting
Eligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Third Party Eligible

CFR § 862.3100 Amphetamine test system

§ 862.3100 Amphetamine test system.

(a) Identification. An amphetamine test system is a device intended to measure amphetamine, a central nervous system stimulating drug, in plasma and urine. Measurements obtained by this device are used in the diagnosis and treatment of amphetamine use or overdose and in monitoring levels of amphetamine to ensure appropriate therapy.

(b) Classification. Class II (special controls). An amphetamine test system is not exempt if it is intended for any use other than employment or insurance testing or is intended for Federal drug testing programs. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9, provided the test system is intended for employment and insurance testing and includes a statement in the labeling that the device is intended solely for use in employment and insurance testing, and does not include devices intended for Federal drug testing programs (e.g., programs run by the Substance Abuse and Mental Health Services Administration (SAMHSA), the Department of Transportation (DOT), and the U.S. military).

[52 FR 16122, May 1, 1987, as amended at 84 FR 71797, Dec. 30, 2019]

Software, Similarity Score Algorithm, Tissue Of Origin For Malignant Tumor Types

Page Type
Product Code
Definition
This test is intended to measure the degree of similarity between the RNA expression pattern in a patient?s fresh-frozen tumor and the RNA expression patterns in a database of tumor samples for some common malignant tumor types that were diagnosed according to then current clinical and pathological practice. The test result is intended for use in the context of the patient?s clinical history and other diagnostic tests evaluated by a qualified clinician. The test is not intended to establish the origin of tumors (e.g. carcinoma of unknown primary) that cannot be diagnosed according to current clinical and pathological practice.
Physical State
Gene expression systems, which include either microarray systems or reverse-transcriptase polymerase chain reaction (RT-PCR) systems. Steps for microarray systems include RNA isolation kits, cDNA synthesis kits, in vitro transcription kits, hybridization, washing and staining systems, scanner, and computer
Technical Method
Uses Gene expression and computer algorithm that estimate degree of similarity between analyzed specimen and examples of various tumor types comprising a database. Gene expression involves isolation of RNA from frozen tumor tissue sections, amplification of RNA and hybridization, and comparison of hybridization patterns.
Target Area
Fresh frozen tumor tissue sections
Regulation Medical Specialty
Toxicology
Review Panel
Toxicology
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
862.3100
GMP Exempt?
No
Summary Malfunction Reporting
Eligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Third Party Eligible

CFR § 862.3100 Amphetamine test system

§ 862.3100 Amphetamine test system.

(a) Identification. An amphetamine test system is a device intended to measure amphetamine, a central nervous system stimulating drug, in plasma and urine. Measurements obtained by this device are used in the diagnosis and treatment of amphetamine use or overdose and in monitoring levels of amphetamine to ensure appropriate therapy.

(b) Classification. Class II (special controls). An amphetamine test system is not exempt if it is intended for any use other than employment or insurance testing or is intended for Federal drug testing programs. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9, provided the test system is intended for employment and insurance testing and includes a statement in the labeling that the device is intended solely for use in employment and insurance testing, and does not include devices intended for Federal drug testing programs (e.g., programs run by the Substance Abuse and Mental Health Services Administration (SAMHSA), the Department of Transportation (DOT), and the U.S. military).

[52 FR 16122, May 1, 1987, as amended at 84 FR 71797, Dec. 30, 2019]